Report
Alpesh Mehta

MOSL: PIRAMAL ENTERPRISES (Buy)-Strong quarter-rapid scale-up of retail housing finance segment

Piramal Enterprises: Strong quarter; rapid scale-up of retail housing finance segment

(PIEL IN, Mkt Cap USD7.6b, CMP INR2766, TP INR3500, 26% Upside, Buy)

  • Piramal Enterprises’ (PIEL) 3QFY18 consolidated PAT grew 21% YoY to INR4.9b, driven by strong growth in financial services business. While PBT grew 50% YoY normalization of tax rate (33% in 3QFY18 vs 17% a year ago) led to 23% YoY growth in reported PAT.
  • Lending business exhibited a strong performance – loan book grew 67% YoY to INR380b, helped by 53% YoY growth in the real estate (RE) lending book. The share of RE lending in overall loans declined to 80% vs 88% a year ago. The share of mezzanine finance declined sequentially from 29% to 24% (35% a year ago). Additionally, the housing book has scaled up well to ~INR5b over the past four months. The company has approved undisbursed sanctions of INR236b in lending business (62% of outstanding loans).
  • Corporate finance book grew 2.6x YoY to INR70b. Around 9% of this book is toward emerging corporates, where the ticket size is in the range of INR100m-INR1b. Overall, RoA/RoE for the lending business for 9MFY17 was 4.1%/21%, while the GNPL ratio was 0.4% v/s 0.2% in 2QFY18.
  • Pharma segment posted moderate growth of 7% YoY to INR10.2b, primarily due to moderate growth of 6% YoY in the global pharma business. The domestic pharma business grew 17% YoY.
Underlying
Piramal Enterprises Ltd.

Piramal Enterprises is a pharmaceutical group based in India. Co. is engaged in the production, packaging, marketing, sale, import, and export of pharmaceutical products in the form of tablets, capsules, liquids, powders, creams, ointments, granules and bulk drug. Co. is engaged in the manufacture of glass containers. Co.'s brands include Phensedyl, Haemaccel, Stemetil, Paraxin, Phenergan, Gardenal, Pentids, Tixylix, Supradyn and Tenormin. Co. maintains over 295 issued patents plus 808 pending patent applications, spread across categories such as compositions of matter, methods of treatments, biomarkers, diagnostics, pharmaceutical compositions and drug delivery systems.

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Alpesh Mehta

Other Reports on these Companies
Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch